However, triple receptor agonism, or agonism/antagonism combinations, can be achieved not only though unimolecular triple agonists, but also by combining mono- and dual-agonists
Tolerability: While all GLP-1s can cause gastrointestinal side effects, your tolerance may vary depending on the drug youre taking
Current obstetrics and gynecology reports, 12(2), 138146
Those changes are what make the biggest difference once treatment stops
This could force you to switch to a different, potentially more expensive medication
FDA approves new drug treatment for chronic weight management, first since 2014, Food and Drug Administration (2021) FDA approves first treatment to reduce risk of serious heart problems specifically in adults with obesity or overweight, Food and Drug Administration (2024) Wegovy prescribing information, Food and Drug Administration (2024) Medically accurate: SingleCares Medical Review Board analyzes all of our content to confirm its in line with current medical advice